Live Breaking News & Updates on Dermatology Medical
Stay updated with breaking news from Dermatology medical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
1. Efficacy of spesolimab appeared to be dose-dependent with high-dose spesolimab leading to a significantly longer time to GPP flare-up versus placebo. 2. There were no treatment-related deaths or hypersensitivity reactions across groups. Evidence Rating Level: 1 (Excellent) Study Rundown: Generalized pustular psoriasis (GPP) is a rare but chronic skin condition with a high morbidity. ....
In part 1 of this 2-part podcast, a panel of experts discusses the provider and payer considerations for transitioning patients to biosimilars, approaches to prescribing biosimilars over reference products, and more. ....
Dermatologists discuss differentiating seborrheic dermatitis from conditions like psoriasis, eczema, and lupus, highlighting similarities and differences with other skin conditions. ....
Business News: Biocon Biologics (BBL) is selling its dermatology and nephrology branded formulations business to Eris Lifesciences for Rs 366 crore. The deal include ....
Peter A. Lio, MD, clinical assistant professor of dermatology and pediatrics at Northwestern University's Feinberg School of Medicine, lists barriers to care for dermatology patients. ....